Cargando…
70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018
BACKGROUND: People living with HIV (PLHIV) are at increased risk of invasive pneumococcal disease (IPD). The 13-valent pneumococcal conjugate vaccine (PCV13) was recommended for children in 2010, and for immunocompromised adults (including PLHIV) in series with 23-valent polysaccharide vaccine (PPSV...
Autores principales: | Matanock, Almea, Li, Jianmin, Adih, William, Xing, Wei, Schaffner, William, Alden, Nisha B, Harrison, Lee, Petit, Susan, Baumbach, Joan, Reingold, Arthur, Almendares, Olivia, Gierke, Ryan, Holtzman, Corinne, Farley, Monica M, Thomas, Ann, Pilishvili, Tamara, Kobayashi, Miwako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644523/ http://dx.doi.org/10.1093/ofid/ofab466.070 |
Ejemplares similares
-
Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014
por: Kobayashi, Miwako, et al.
Publicado: (2017) -
1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020) -
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Matanock, Almea, et al.
Publicado: (2019) -
Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017) -
1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
por: Matanock, Almea, et al.
Publicado: (2018)